Obstetricians: Want to know what your patients wish you had told them before delivery? We surveyed a group of moms and are sharing the top 10 responses.
Spending on screening mammography has increased 44% ($296 million) in 8 years, without a corresponding increased benefit of earlier detection of breast cancer.
The American College of Physicians (ACP) recommends against pelvic exams in asymptomatic, nonpregnant, adult women. Some say this is faulty logic. What say you?
Obstetricians agree they should have a role in reducing pregnant women’s exposure to environmental toxins, but most fail to discuss the subject with patients.
These simple tips can help pregnant patients reduce their exposure to environmental toxins and harmful chemicals, such as lead, mercury, BPA, and phthalates.
Breast tomosynthesis may be worth the extra cost to patients for breast cancer screening. Research shows the 3D technology finds more invasive cancers earlier.
This infographic reveals the breast cancer screening practices of fellow ObGyn.net readers. How do your recommendations compare with those of your colleagues?
Most older women with non-metastatic, estrogen-positive breast cancer initiate recommended treatment with an aromatase inhibitor or tamoxifen, research shows.
The growing number of women who are opting for a double mastectomy after a cancer diagnosis suggests better education about the risk and benefits of the procedure is needed.
Physicians can help older women make informed mammography decisions by taking into account life expectancy and the harms and benefits of breast cancer screening.